Hassan, M.S. and Jawad, A.M. (2026) “Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer”, Middle Eastern Cancer and Oncology Journal, 2(3), pp. 1–9. doi:10.61706/MECOJ160229.